Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kaminski

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biochemical and Biophysical Research Communications|February 19, 2000
Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1L Shan, X Qiao, E Oldham, et al.
Archives of Neurology|April 18, 2000
Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotoniaA Mygland, A Vincent, J Newsom-Davis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 18, 2003
Anti-titin antibodies are not associated with a specific thymoma histologyR Voltz, W Albrich, R Hohlfeld, et al.
Open Forum Infectious Diseases|February 23, 2023
Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug ResistanceM Acquier, B Taton, S Alain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptorsC H Jenh, M A Cox, H Kaminski, et al.
JAMA Neurology|December 31, 2019
Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS)Christina N Fournier, Richard Bedlack, Colin Quinn, et al.
Transplantation Proceedings|June 4, 2013
Maribavir use in practice for cytomegalovirus infection in French transplantation centersS Alain, M Revest, D Veyer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 6, 2023
Specificities of Meningitis and Meningo-Encephalitis After Kidney Transplantation: A French Retrospective Cohort StudyY Tamzali, A Scemla, T Bonduelle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2025
Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infectionN Kasriel, S Alain, I Benotmane, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biochemical and Biophysical Research Communications|February 19, 2000
Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1L Shan, X Qiao, E Oldham, et al.
Archives of Neurology|April 18, 2000
Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotoniaA Mygland, A Vincent, J Newsom-Davis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 18, 2003
Anti-titin antibodies are not associated with a specific thymoma histologyR Voltz, W Albrich, R Hohlfeld, et al.
Open Forum Infectious Diseases|February 23, 2023
Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug ResistanceM Acquier, B Taton, S Alain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptorsC H Jenh, M A Cox, H Kaminski, et al.
JAMA Neurology|December 31, 2019
Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS)Christina N Fournier, Richard Bedlack, Colin Quinn, et al.
Transplantation Proceedings|June 4, 2013
Maribavir use in practice for cytomegalovirus infection in French transplantation centersS Alain, M Revest, D Veyer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 6, 2023
Specificities of Meningitis and Meningo-Encephalitis After Kidney Transplantation: A French Retrospective Cohort StudyY Tamzali, A Scemla, T Bonduelle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2025
Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infectionN Kasriel, S Alain, I Benotmane, et al.
Pageof 2